300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Travel
Local
Enterprise Software
InsurTech
Platforms
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Renewable Energy
Software
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Theatre
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Medical
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Recruiting
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Mexico
Nigeria
Zimbabwe
Zambia
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Norway
Madagascar
Pakistan
Tajikistan
Oman
Romania
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
New Zealand
Uzbekistan
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Middle East
Indonesia
Asia
Dominican Republic
Bermuda
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Bangladesh
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Siimon Vaske, Fund Manager and Chief Executive Officer at Trio Impact Invest

Siimon Vaske

Fund Manager and Chief Executive Officer @ Trio Impact Invest

Siimon Vaske is a seed investor at Trio Impact Invest focused on Biotechnology and Biopharma.

Total investments:
3
Last investment:
Lead investor:
100%

Last updated:

Industries Siimon Vaske invests in

BiotechnologyBiopharmaCleanTechClean EnergyPharmaceutical

Stages Siimon Vaske invests in

SeedPre-SeedVenture - Series Unknown

Countries Siimon Vaske invests in

Sweden

Investment Focus

Industry

  • Biotechnology 2 (67%)
  • Biopharma 1 (33%)
  • CleanTech 1 (33%)
  • Clean Energy 1 (33%)
  • Pharmaceutical 1 (33%)

Stage

  • Seed 1 (33%)
  • Pre-Seed 1 (33%)
  • Venture - Series Unknown 1 (33%)

Investments

CompanyDescriptionRoundLinks
Caplyzer Caplyzer
Caplyzer develops and patented a new solution for water electrolysis. $726.6K / Seed / Jul 07, 2026
GenomeVault GenomeVault
GenomeVault is a biodiversity startup that converts eDNA from nature into scalable biodiversity insights using advanced genomics. $515.3K / Pre-Seed / Jul 07, 2026
AAX Biotech AAX Biotech
AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies. Venture - Series Unknown / Feb 19, 2026

Co-Investors

Trio Impact Invest

About Trio Impact Invest

VC Fund

Trio Impact Invest is a venture capital investment firm.

Trio Impact Invest Contacts

NameEmailPhoneSocials
Siimon Vaske
Siimon Vaske Fund Manager and Chief Executive Officer

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Open Trio Impact Invest full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Travel
Local
Enterprise Software
InsurTech
Platforms
Retail
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Renewable Energy
Software
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Theatre
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Medical
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Recruiting
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Mexico
Nigeria
Zimbabwe
Zambia
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Norway
Madagascar
Pakistan
Tajikistan
Oman
Romania
Poland
Puerto Rico
Andorra
Cameroon
Guernsey
Sudan
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
New Zealand
Uzbekistan
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Middle East
Indonesia
Asia
Dominican Republic
Bermuda
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Bangladesh
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Siimon Vaske invest in?

Siimon Vaske invests primarily in Biotechnology, Biopharma and CleanTech startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Siimon Vaske last invest?

The most recent investment recorded for Siimon Vaske closed in Jul 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Siimon Vaske Siimon Vaske Find email